384 related articles for article (PubMed ID: 16195368)
1. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
Townsend KP; Praticò D
FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
[TBL] [Abstract][Full Text] [Related]
2. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action.
Gasparini L; Ongini E; Wenk G
J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484
[TBL] [Abstract][Full Text] [Related]
3. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
[TBL] [Abstract][Full Text] [Related]
4. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
Gasparini L; Ongini E; Wilcock D; Morgan D
Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
[TBL] [Abstract][Full Text] [Related]
5. Coxibs and Alzheimer's disease: should they stay or should they go?
Firuzi O; Praticò D
Ann Neurol; 2006 Feb; 59(2):219-28. PubMed ID: 16402383
[TBL] [Abstract][Full Text] [Related]
6. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
[TBL] [Abstract][Full Text] [Related]
7. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
Bernardo A; Ajmone-Cat MA; Gasparini L; Ongini E; Minghetti L
J Neurochem; 2005 Feb; 92(4):895-903. PubMed ID: 15686492
[TBL] [Abstract][Full Text] [Related]
8. No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease.
Hillmann A; Hahn S; Schilling S; Hoffmann T; Demuth HU; Bulic B; Schneider-Axmann T; Bayer TA; Weggen S; Wirths O
Neurobiol Aging; 2012 Apr; 33(4):833.e39-50. PubMed ID: 21943956
[TBL] [Abstract][Full Text] [Related]
9. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
Hirohata M; Ono K; Naiki H; Yamada M
Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740
[TBL] [Abstract][Full Text] [Related]
10. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
Pasinetti GM
J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
[TBL] [Abstract][Full Text] [Related]
11. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
12. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].
de Jong D; Jansen RW; Verbeek MM; Kremer HP
Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
14. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity.
Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH
Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559
[TBL] [Abstract][Full Text] [Related]
15. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease.
Sung S; Yang H; Uryu K; Lee EB; Zhao L; Shineman D; Trojanowski JQ; Lee VM; Praticò D
Am J Pathol; 2004 Dec; 165(6):2197-206. PubMed ID: 15579461
[TBL] [Abstract][Full Text] [Related]
16. The role of inflammation in Alzheimer's disease.
Tuppo EE; Arias HR
Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
Pasinetti GM
J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
[TBL] [Abstract][Full Text] [Related]
18. Effects of non-steroidal anti-inflammatory drugs on Abeta deposition in Abeta(1-42) transgenic C. elegans.
Morita M; Osoda K; Yamazaki M; Shirai F; Matsuoka N; Arakawa H; Nishimura S
Brain Res; 2009 Oct; 1295():186-91. PubMed ID: 19666013
[TBL] [Abstract][Full Text] [Related]
19. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
van Groen T; Kadish I
Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
[TBL] [Abstract][Full Text] [Related]
20. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.
Imbimbo BP
Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
